Medication info

EVICEL

Prescription medicationApproval withdrawn
Ingredient · strength
Clottable Protein›Strength being verifiedHuman Thrombin›Strength being verified
Manufacturer / importer
Johnson & Johnson Medical Korea Co. Ltd.
Appearance
This medicine consists of a kit with two glass vials. Each vial contains an opaque frozen liquid that has a white to light yellow appearance, which turns into a colorless to light yellow clear liquid upon thawing.
Packaging
2 mL / kit, 4 mL / kit, 10 mL / kit
Approval status
Approval withdrawn

MFDS item code 201209716 · Approved 2012.12.14

This product's status changed to Approval withdrawn on 2023.11.01. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Adjunctive control and relief of bleeding that is difficult to control with standard surgical techniques during surgery
Who uses it
Adults
Adult dosage
The amount and frequency of application of this medicine should always be based on the patient's clinical needs. The amount used varies according to the type of surgery, the size of the application site, the method of application, and the number of applications, and should be determined by the attending physician for each patient. In clinical trials in vascular surgery, the individual dose was up to 4mL, whereas in retroperitoneal or intra-abdominal surgery, the individual dose was up to 10mL. However, a larger amount may be needed for some procedures (e.g., liver trauma). The initial amount of product applied to the selected anatomical site or target surface should be sufficient to completely cover the application site. It may be reapplied as needed.

Ingredients

Importer
Johnson & Johnson Medical Korea Co. Ltd.

Efficacy & effects

Adjunctive control and relief of bleeding that is difficult to control with standard surgical techniques during surgery

View approved original text

This medicine helps effectively stop bleeding when bleeding during surgery cannot be adequately controlled by standard surgical methods, such as suturing, clipping, or cauterization. In other words, it aids in hemostasis in situations where controlling bleeding during surgery is difficult, thereby promoting patient safety. It is used to improve bleeding issues in such cases.

Dosage and Administration

Adult dosage

The amount and frequency of application of this medicine should always be based on the patient's clinical needs. The amount used varies according to the type of surgery, the size of the application site, the method of application, and the number of applications, and should be determined by the attending physician for each patient. In clinical trials in vascular surgery, the individual dose was up to 4mL, whereas in retroperitoneal or intra-abdominal surgery, the individual dose was up to 10mL. However, a larger amount may be needed for some procedures (e.g., liver trauma). The initial amount of product applied to the selected anatomical site or target surface should be sufficient to completely cover the application site. It may be reapplied as needed.

Precautions

Since this medicine is made from human plasma, there may be a risk of viral or infectious agents that can be transmitted through blood, although rare. Therefore, patients with hemophilia or those with weakened immune systems should receive vaccinations, such as the hepatitis A vaccine, and should regularly check for infections after administration. This medicine should only be applied to wound surfaces, and administering it into blood vessels can lead to serious complications such as thrombosis or vascular embolism, so it must not be injected into blood vessels. Additionally, it should not be used in patients with allergies or hypersensitivity to any of its components. It is prohibited to use in a spray form during endoscopic procedures, and caution is necessary during laparoscopic surgeries. Patients with hemolytic anemia or hemorrhagic anemia, and those with compromised immune systems should be careful in using this medicine due to the risk of viral infection present in the product. Rarely, this medicine may cause allergic reactions, hives, shortness of breath, or hypotension, and in severe cases, it may progress to anaphylactic shock. Such reactions may be more pronounced in patients who are hypersensitive to the components or those using it repeatedly, so caution is recommended. If intravascular injection occurs accidentally, dangerous conditions such as thrombosis or disseminated intravascular coagulation (DIC) may arise, so utmost care is necessary. When this medicine is used with a nebulizer, the recommended pressure and distance must be maintained; otherwise, life-threatening air embolism may occur. As a drug derived from human blood, the risks of infections such as HIV or hepatitis viruses cannot be completely excluded, so the patient's condition must be closely monitored after use. Pregnant women or those who may become pregnant should use this drug only when the benefits of treatment outweigh the risks due to the potential risk of viral infections to the fetus. Nursing mothers should also only use this drug when absolutely necessary as sufficient safety has not been verified for its use during breastfeeding. This drug should not be mixed with other medications, and must be cleaned off any substances such as alcohol or disinfectants before use as it may degrade. For storage, it should be kept in a sealed container to avoid contact with air, and stored frozen at below -18 degrees Celsius. Doing so will maintain the drug's effectiveness and prevent degradation. Finally, it is essential to always document the manufacturing number and the patient's name for traceability when using this medicine, and to apply it safely following the recommended usage and devices.

Side effects

Hypersensitivity reaction, allergic reaction, angioedema, burning and tingling at the application site, bronchospasm, chills, flushing, generalized urticaria, headache, hives, hypotension, lethargy, nausea, anxiety, tachycardia, chest tightness, soreness, vomiting, wheezing, thrombosis, disseminated intravascular coagulation, anaphylaxis, air or gas embolism, intra-abdominal abscess, transplant infection, Staphylococcus infection, hematoma, peripheral edema, hemoglobin reduction, incision site bleeding, vascular graft occlusion, postoperative hematoma, postoperative wound complications, hives, chest tightness, wheezing, hypotension, anaphylaxis

Not everyone experiences these, and they can vary from person to person.

Storage

This medicine should be stored in a sealed container to prevent contact with air and kept frozen at a temperature below -18 degrees Celsius. By doing this, the drug's effectiveness can be maintained and degradation can be prevented.

Appearance and packaging

Appearance

This medicine consists of a kit with two glass vials. Each vial contains an opaque frozen liquid that has a white to light yellow appearance, which turns into a colorless to light yellow clear liquid upon thawing.

Package unit

2 mL / kit, 4 mL / kit, 10 mL / kit

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.